| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.39B | 11.67B | 12.84B | 14.93B | 16.02B | 15.44B |
| Gross Profit | 802.00M | 899.00M | 927.00M | 989.00M | 1.05B | 944.00M |
| EBITDA | 537.00M | 802.00M | 488.00M | 621.00M | 454.00M | 544.00M |
| Net Income | -129.00M | 373.00M | 108.00M | 276.00M | -101.00M | 205.00M |
Balance Sheet | ||||||
| Total Assets | 5.83B | 6.19B | 6.34B | 7.03B | 6.67B | 7.74B |
| Cash, Cash Equivalents and Short-Term Investments | 547.00M | 898.00M | 542.00M | 697.00M | 418.00M | 625.00M |
| Total Debt | 1.49B | 1.70B | 1.49B | 1.67B | 1.25B | 1.38B |
| Total Liabilities | 3.73B | 3.90B | 3.96B | 4.49B | 4.22B | 5.06B |
| Stockholders Equity | 2.10B | 2.29B | 2.38B | 2.54B | 2.44B | 2.69B |
Cash Flow | ||||||
| Free Cash Flow | 245.00M | 8.00M | 224.00M | -91.00M | 73.00M | 295.00M |
| Operating Cash Flow | 521.00M | 381.00M | 592.00M | 225.00M | 526.00M | 676.00M |
| Investing Cash Flow | -306.00M | 297.00M | -255.00M | -129.00M | -292.00M | -357.00M |
| Financing Cash Flow | -265.00M | -333.00M | -439.00M | 191.00M | -439.00M | -43.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £492.68M | 22.53 | 6.40% | 9.48% | 0.58% | 61.58% | |
70 Outperform | £163.92M | 8.69 | 18.25% | 2.00% | 15.56% | -92.94% | |
66 Neutral | £3.96B | 60.70 | 6.17% | 3.45% | 2.36% | -13.99% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £3.16B | -46.91 | -5.87% | 3.54% | -4.60% | -126.46% | |
58 Neutral | £840.02M | -28.06 | -6.85% | 1.34% | -11.78% | -92.61% | |
51 Neutral | £58.88M | -1.25 | -7.26% | ― | -4.41% | 2.29% |